2 Dividend ETFs to Avoid and 1 to Buy Right Now

With investors anticipating a December rate cut but facing liquidity constraints, the author recommends trimming concentrated tech exposures and rotating into income-focused ETFs. VanEck SMH (YTD +43.9%, 5yr +220%) is flagged for concentration risk — NVDA is ~16.94% and the top 10 holdings account for ~75% — and State Street XLK (YTD +23.4%) is similarly top-heavy (NVDA ~14.26%, top 10 ~62.21%), raising downside risk of a 30–40% correction. The suggested alternative is Amplify CWP Enhanced Dividend Income ETF (DIVO), which holds AXP/IBM/RTX, pays monthly dividends at a ~4.55% yield and charges a 0.56% expense ratio, offering lower drawdowns and income while markets de-risk.

Analysis

Market structure: Tech/AI winners (NVDA, select AI software) remain beneficiaries of secular demand but ETF concentration (SMH 16.9% NVDA, XLK 14.3% NVDA; top-10 = 62–75% of assets) creates asymmetric downside: a 20–40% cyclic drawdown in semis/tech would quickly cascade through passive flows and liquidity. Defensive income names (AXP, IBM, RTX) and covered-call wrappers (DIVO, yield ~4.55%) gain relative funding advantage as investors pay to de-risk and collect carry over the next 3–12 months.

Risk assessment: Tail risks include an NVDA earnings miss or export/regulatory action (China/US export controls) that could drive a >30% shock to SMH/XLK within days; second-order risks are margin-call cascades from crowded long-vol positions and ETF redemption pressure. Short-term (days–weeks) expect elevated realized volatility in NVDA/SMH/XLK; medium-term (months) rotation into yield if Fed signals pivots; long-term (quarters–years) semis remain structurally strong if AI demand persists but pricing power may compress if capacity ramps faster than demand.

Trade implications: Tactical plays: trim concentrated ETF exposure and buy premium on downside protection — implied vol skew favors put spreads on NVDA/XLK for 1–3 month horizons ahead of Fed and earnings. Rotate 2–5% into DIVO or direct AXP/IBM exposure to harvest 3.5–5% income, and use pair trades (long DIVO, short SMH/XLK) to reduce net tech beta while preserving upside optionality.

Contrarian angles: Consensus underestimates the probability that NVDA stays a duopoly winner; if supply tightness persists, semis could re-rate—so avoid permanent cuts, favor timed re-entry triggers. DIVO's covered-call strategy can underperform in a prolonged risk-on melt-up; don’t over-allocate above 5% without a firm macro view. Historical parallel: 2000 concentration risk warns of fast drawdowns, but stronger fundamentals (cash flow, margins) argue corrections, not extinction.

Key Decisions for Investors

• Within 10 trading days, reduce aggregate SMH and XLK exposure by ~30% (each) if combined portfolio NVDA exposure exceeds 7.5%; redeploy proceeds: 60% into DIVO (up to 3% portfolio weight) and 40% into cash/T-bills to preserve dry powder.
• Establish a 2–3% long position in Amplify CWP Enhanced Dividend Income ETF (DIVO) and hold 6–12 months to capture ~4.5% yield; exit or trim if trailing yield falls below 3.5% or NAV declines >10% over a 3-month window.
• Buy downside protection: for every $1M of tech equity exposure purchase a 3-month NVDA put spread sized to hedge a 5–10% portfolio loss (e.g., long 10% OTM puts financed by selling 25% OTM puts) ahead of next Fed meeting/quarterly earnings.
• Implement a pair trade: long 3% DIVO and short 2% SMH (or equivalent notional short across XLK/SMH) to reduce net tech beta; add to longs if NVDA declines >25% from its recent high and liquidity conditions visibly stabilize over 4–8 weeks.